Kavita Sangwan
Panipat, HR, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Emerging drug profile: menin inhibitors in NPM1-mutated and KM2A-rearranged acute myeloid leukemia.
Journal: Leukemia & lymphoma
Published: May 27, 2026
FDA-Approved Radiopharmaceuticals in Oncologic PET Imaging: Current Status and Clinical Impact.
Journal: American journal of clinical oncology
Published: January 14, 2026
Sunvozertinib: a Promising Oral EGFR Inhibitor Approved for NSCLC with EGFR Ex20ins Mutations.
Journal: Investigational new drugs
Published: August 14, 2025
Pharmacological aspects of FDA-approved novel drug therapies against cancer in 2023: a comprehensive review.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: February 05, 2025
Pharmacological Insights on USFDA-approved Novel Drug Therapies in the Year 2023.
Journal: Current drug discovery technologies
Published: December 19, 2024
Tarlatamab-dlle: A New Hope for Patients with Extensive-Stage Small-Cell Lung Cancer.
Journal: Current treatment options in oncology
Published: September 25, 2024
A Review on Medicinal Approaches of Novel Imatinib Derivatives.
Journal: Current topics in medicinal chemistry
Published: June 14, 2024
Pharmacological Profile of Novel Anti-cancer Drugs Approved by USFDA in 2022: A Review.
Journal: Current molecular medicine
Published: March 14, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026